bioRxiv Science⌕ Search

Biology subjects

Lodhiya, T.

Publications and source records attributed to Lodhiya, T..

3 recordsLinked to original sources

Mycobacteriophage TM4 requires XylR for successful infection in Mycobacterium smegmatis mc2155

Mycobacteriophages are viruses that infect mycobacteria, including Mycobacterium tuberculosis, and have emerged as promising alternatives to antibiotics in the face of increasing antimicrobial resistance. However, evolution of phage-resistance remains a major challenge to the clinical implementation of phage therapy. We describe a TM4 phage resistant mutant in M. smegmatis harboring an in-frame deletion in the xylR, transcriptional regulator implicated in lipid metabolism, and cell envelope homeostasis. Using spontaneous mutagenesis, transcriptomics and biochemical approaches, we identify a previously uncharacterized resistance mechanism mediated by cell-envelope remodeling that impedes productive phage infection. The xylR mutation disrupted phage DNA injection through enhanced recruitment of lipooligosaccharides to the cell surface, without inhibiting phage adsorption, genome replication, and virion assembly. Remodeling of the cell envelope was further enhanced by the induction of lipooligosaccharide biosynthesis upon TM4 infection, however, the phenotype can be reverted through chemical treatment, restoring phage sensitivity. Our study expands the paradigm of innate mechanisms underlying broad-spectrum phage resistance in mycobacteria.

microbiology↗

ATP burst is the dominant driver of antibiotic lethality in Mycobacteria

AbstractAntibiotic-tolerant bacteria, due to their unique physiology, are refractory to antimicrobial killing and pose challenges for infection control. Incomplete knowledge of how bactericidal antibiotics work, limits our understanding of partial resistance due to phenotypic tolerance in mycobacteria, a driver for developing genetic resistance. Using proteomics, 13C isotopomer analysis, genetic and biochemical assays, we investigated the physiological response of M. smegmatis challenged with aminoglycoside and fluoroquinolone antibiotics. Two distinct classes of antibiotics elicited remarkably similar responses and increased flux through the TCA cycle, causing enhanced respiration, ROS generation, and ATP burst. We observed that excessive ATP levels and not ROS, dominantly contributes to cidality, which may in part be, conferred by sequestration of divalent metal ions by ATP. Consequently, 13C isotope tracing indicated TCA cycle flux deviation from its oxidative arm as a bacterial adaptive mechanism, which also included activated intrinsic resistance and a higher propensity to develop antibiotic resistance. Our study provides a new understanding of the intricate mechanisms of antibiotic-induced cell death and expands the current paradigm for antibiotic action.

microbiology↗

Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles

Tuberculosis (TB) is one of the most widely prevalent infectious diseases that cause significant mortality. Bacillus Calmette-Guerin (BCG), the current TB vaccine used in clinics, shows variable efficacy and has safety concerns for immunocompromised patients. There is a need to develop new and more effective TB vaccines. Outer membrane vesicles (OMVs) are vesicles released by Mycobacteria that contain several lipids and membrane proteins and act as a good source of antigens to prime immune response. However, the use of OMVs as vaccines has been hampered by their heterogeneous size and low stability. Here we report that mycobacterial OMVs can be stabilized by coating over uniform-sized 50 nm gold nanoparticles. The OMV-coated gold nanoparticles (OMV-AuNP) show enhanced uptake and activation of macrophages and dendritic cells. Proteinase K and TLR inhibitor studies demonstrated that the enhanced activation was attributed to proteins present on OMVs and was mediated primarily by TLR2 and TLR4. Mass spectrometry analysis revealed several potential membrane proteins that were common in both free OMVs and OMV-AuNP. Such strategies may open up new avenues and the utilization of novel antigens for developing TB vaccines.

bioengineering↗